Robin Hayes
Eliminating Hepatic Stellate Cells Halts Liver Metastasis in Mouse Models
In a landmark discovery published on June 10, 2025 in Hepatology Communications, researchers at the University of the Basque Country (EHU) have demonstrated that removing activated hepatic stellate cells (HSCs) from the liver virtually eliminates metastatic tumor growth in mouse models. The finding not only overturns long-held assumptions about the benign role of HSCs in liver repair but also identifies a promising new target for therapies aimed at preventing or treating liver metastases from a variety of primary cancers.
· 5 min read
